Current status of physicians’ perception of HCC conversion/downstaging therapy: A nationwide survey in China. A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination ...
TORONTO, ONTARIO--(Marketwired - Feb 21, 2017) - Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutics, is ...
Association of RecQ1 A159C polymorphism with overall survival of patients with resected pancreatic cancer: A replication study in RTOG 9704. Background: GIDEON is an ongoing, global, prospective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results